首页> 美国卫生研究院文献>Biochemical Journal >Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis.
【2h】

Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis.

机译:线粒体3-羟基-3-甲基戊二酰辅酶A合酶:生酮中的控制酶。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cytosolic and mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthases were first recognized as different chemical entities in 1975, when they were purified and characterized by Lane's group. Since then, the two enzymes have been studied extensively, one as a control site of the cholesterol biosynthetic pathway and the other as an important control site of ketogenesis. This review describes some key developments over the last 25 years that have led to our current understanding of the physiology of mitochondrial HMG-CoA synthase in the HMG-CoA pathway and in ketogenesis in the liver and small intestine of suckling animals. The enzyme is regulated by two systems: succinylation and desuccinylation in the short term, and transcriptional regulation in the long term. Both control mechanisms are influenced by nutritional and hormonal factors, which explains the incidence of ketogenesis in diabetes and starvation, during intense lipolysis, and in the foetal-neonatal and suckling-weaning transitions. The DNA-binding properties of the peroxisome-proliferator-activated receptor and other transcription factors on the nuclear-receptor-responsive element of the mitochondrial HMG-CoA synthase promoter have revealed how ketogenesis can be regulated by fatty acids. Finally, the expression of mitochondrial HMG-CoA synthase in the gonads and the correction of auxotrophy for mevalonate in cells deficient in cytosolic HMG-CoA synthase suggest that the mitochondrial enzyme may play a role in cholesterogenesis in gonadal and other tissues.
机译:胞质和线粒体3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)合成酶于1975年被纯化并由Lane的研究小组鉴定为不同的化学实体。从那以后,对这两种酶进行了广泛的研究,一种酶是胆固醇生物合成途径的控制位点,另一种酶是生酮的重要控制位点。这篇综述描述了过去25年中的一些重要进展,这些进展使我们对HMG-CoA途径中的线粒体HMG-CoA合酶的生理学以及肝脏和哺乳动物小肠的生酮作用有了新的认识。该酶由两个系统调节:短期内琥珀酰化和去琥珀酰化,以及长期上转录调节。两种控制机制均受营养和激素因素的影响,这解释了糖尿病和饥饿,强烈脂解期间以及胎儿-新生儿和哺乳-断奶转变中生酮的发生率。过氧化物酶体增殖物激活的受体和其他转录因子在线粒体HMG-CoA合酶启动子的核受体响应元件上的DNA结合特性揭示了如何通过脂肪酸调节生酮作用。最后,线粒体HMG-CoA合酶在性腺中的表达以及在缺乏胞质HMG-CoA合酶的细胞中甲羟戊酸的营养缺陷的校正表明,线粒体酶可能在性腺和其他组织的胆固醇生成中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号